Literature DB >> 3082872

Isolation and characterization of proteoglycans secreted by normal and malignant human mammary epithelial cells.

D C Gowda, V P Bhavanandan, E A Davidson.   

Abstract

The proteoglycans secreted by a malignant human breast cell line (MDA-MB-231) were compared with the corresponding proteoglycans from a normal human breast cell line (HBL-100). The physicochemical characteristics of these proteoglycans were established by hexosamine analysis, chemical and enzymatic degradations, and dissociative cesium chloride density gradient centrifugation, and by gel filtration before and after alkaline beta-elimination. Both cell lines secreted approximately 70% of the synthesized proteoglycans, which were composed of 20% heparan sulfate and 80% chondroitin sulfate proteoglycans. The MDA cell line secreted large hydrodynamic size (major) and small hydrodynamic size heparan sulfate proteoglycan. In contrast HBL cells secreted only one species having a hydrodynamic size intermediate to the above two. The chondroitin sulfate proteoglycans from MDA medium were slightly larger than the corresponding polymers from HBL medium. All proteoglycans except the small hydrodynamic size heparan sulfate proteoglycan from MDA medium were of high buoyant density. The proteoglycans of both cell lines contained significant proportions of disulfide-linked lower molecular weight components which were more pronounced in the proteoheparan sulfate polymers, particularly those from MDA medium, than in chondroitin sulfate proteoglycans. The glycosaminoglycans of heparan sulfate proteoglycans from MDA medium were more heterogeneous than those from HBL medium. The glycosaminoglycan chains of large hydrodynamic size heparan sulfate proteoglycans from MDA medium were larger in size than those from HBL medium while small hydrodynamic size heparan sulfate proteoglycans contained shorter glycosaminoglycan chains. In contrast to the glycosaminoglycans derived from chondroitin sulfate proteoglycans of both MDA and HBL medium were comparable in size. The heparan sulfate as well as chondroitin sulfate proteoglycans of both cell lines contained both neutral (di- and tetrasaccharides) and sialylated (tri- to hexasaccharides) O-linked oligosaccharides.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3082872

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Effect of low-density lipoproteins on the synthesis and secretion of proteoglycans by human endothelial cells in culture.

Authors:  P Vijayagopal; S R Srinivasan; E R Dalferes; B Radhakrishnamurthy; G S Berenson
Journal:  Biochem J       Date:  1988-10-15       Impact factor: 3.857

2.  Nanoplex delivery of siRNA and prodrug enzyme for multimodality image-guided molecular pathway targeted cancer therapy.

Authors:  Cong Li; Marie-France Penet; Flonné Wildes; Tomoyo Takagi; Zhihang Chen; Paul T Winnard; Dmitri Artemov; Zaver M Bhujwalla
Journal:  ACS Nano       Date:  2010-10-19       Impact factor: 15.881

3.  Suppression of HIV-1 Infectivity by Human Glioma Cells.

Authors:  Sheikh Ariful Hoque; Atsushi Tanaka; Salequl Islam; Gias Uddin Ahsan; Atsushi Jinno-Oue; Hiroo Hoshino
Journal:  AIDS Res Hum Retroviruses       Date:  2016-01-07       Impact factor: 2.205

4.  Physical properties of chondroitin sulphate/dermatan sulphate proteoglycans from bovine aorta.

Authors:  R Kapoor; C F Phelps; T N Wight
Journal:  Biochem J       Date:  1986-12-01       Impact factor: 3.857

5.  Interferon effect on glycosaminoglycans in mouse glioma in vitro.

Authors:  M Wiranowska; A K Naidu
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

6.  Heparin sequences in the heparan sulfate chains of an endothelial cell proteoglycan.

Authors:  H B Nader; C P Dietrich; V Buonassisi; P Colburn
Journal:  Proc Natl Acad Sci U S A       Date:  1987-06       Impact factor: 11.205

7.  Enhanced synthesis and accumulation of proteoglycans in cholesterol-enriched arterial smooth muscle cells.

Authors:  P Vijayagopal
Journal:  Biochem J       Date:  1993-09-01       Impact factor: 3.857

8.  A cell surface chondroitin sulfate proteoglycan, immunologically related to CD44, is involved in type I collagen-mediated melanoma cell motility and invasion.

Authors:  A E Faassen; J A Schrager; D J Klein; T R Oegema; J R Couchman; J B McCarthy
Journal:  J Cell Biol       Date:  1992-01       Impact factor: 10.539

9.  Breast cancer: coordinated regulation of CCL2 secretion by intracellular glycosaminoglycans and chemokine motifs.

Authors:  Yaeli Lebel-Haziv; Tsipi Meshel; Gali Soria; Adva Yeheskel; Elad Mamon; Adit Ben-Baruch
Journal:  Neoplasia       Date:  2014-09       Impact factor: 5.715

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.